Questo Quaderno presenta la prima release del modello SaniRegio per l'analisi la spesa sanitaria pubblica nelle Regioni italiane. L'analisi delle differenze regionali evidenzia quanta parte della spesa possa trovare giustificazione, da un lato, nelle caratteristiche demografiche, economiche e...

La letteratura suggerisce che l'applicazione del reference pricing avvenga solo sugli off-patent, sulla base di cluster chimico-terapeutico-biologici, con prezzo di rimborso allineato a quello del prodotto più economico. Non mancano, tuttavia, segnalazioni di criticità, riconducibili alle...

Questo Working Paper risponde a due quesiti: 1) Quale distribuzione di risorse tra Regioni emergerebbe se i 106,4 miliardi di Euro del Fsn-2011 fossero ripartiti in maniera tale da riconoscere, su tutto il territorio nazionale, i medesimi rapporti di fabbisogno pro-capite tra fasce di età che...

Si presenta la prima versione di FarmaRegio, modello econometrico per l'analisi della variabilità regionale della spesa farmaceutica territoriale convenzionata (un panel ad effetti casuali). Si suggeriscono due prospettive di lettura: da un lato, la valutazione della significatività delle...

This paper provides an update and reanalysis of my previously published article, Rhetorical Federalism: The Value of State-Based Dissent to Federal Health Reform, 93 Hofstra Law Review 111 (2010). In Rhetorical Federalism, I made an affirmative case for the widespread trend of state resistance...

Although mandated by federal law, Medicaid always has been fundamentally a matter of state business, primarily because states administer the program and receive only partial federal reimbursement for state expenditures. As health care costs have burgeoned over the past few decades, states have...

In its decades-long effort to assure the safety, efficacy, and security of medicines and other products, the Food and Drug Administration has struggled with issues of funding, proper associations with industry, and the balance between consumer choice and consumer protection. Today, these...

Proponents of the Patient Protection and Affordable Care Act of 2010 (ACA) set forth two primary goals: (1) to constrain health care costs and (2) to expand health insurance coverage. In its June 28, 2012 decision upholding the constitutionality of the ACA, the U.S. Supreme Court effectively...

Is President Obama’s health-care law dead? Ever since the United States Supreme Court heard arguments about its constitutionality in late March, speculation has been rife that, at a minimum, the Justices will strike down the individual mandate. The predictions rest on a single assertion: that...

This thesis consists of a summary and four papers. The first two concerns health care and sickness absence, and the last two pharmaceutical costs and prices. <p> Paper [I] presents an economic federation model which resembles the situation in, for example, Sweden. In the model the state governments...</p>